Table of Content
?TABLE OF CONTENTS
1 Research Methodology and Statistical Scope 1
1.1 Market Definition and Statistical Scope of Induced Pluripotent Stem Cells (iPSc) 1
1.2 Key Market Segments 1
1.2.1 Induced Pluripotent Stem Cells (iPSc) Segment by Type 1
1.2.2 Induced Pluripotent Stem Cells (iPSc) Segment by Application 2
1.3 Methodology & Sources of Information 3
1.3.1 Research Methodology 3
1.3.2 Research Process 4
1.3.3 Market Breakdown and Data Triangulation 5
1.3.4 Base Year 5
1.3.5 Report Assumptions & Caveats 6
2 Induced Pluripotent Stem Cells (iPSc) Market Overview 8
2.1 Global Market Overview 8
2.1.1 Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) Estimates and Forecasts (2017-2028) 8
2.1.2 Global Induced Pluripotent Stem Cells (iPSc) Sales Estimates and Forecasts (2017-2028) 9
2.2 Market Segment Executive Summary 9
2.3 Global Market Size by Region 11
3 Induced Pluripotent Stem Cells (iPSc) Market Competitive Landscape 13
3.1 Global Induced Pluripotent Stem Cells (iPSc) Sales by Manufacturers (2017-2022) 13
3.2 Global Induced Pluripotent Stem Cells (iPSc) Revenue Market Share by Manufacturers (2017-2022) 15
3.3 Induced Pluripotent Stem Cells (iPSc) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 16
3.4 Global Induced Pluripotent Stem Cells (iPSc) Average Price by Manufacturers (2017-2022) 17
3.5 Manufacturers Induced Pluripotent Stem Cells (iPSc) Sales Sites, Area Served, Product Type 18
3.6 Induced Pluripotent Stem Cells (iPSc) Market Competitive Situation and Trends 19
3.6.1 Induced Pluripotent Stem Cells (iPSc) Market Concentration Rate 19
3.6.2 Global 5 and 10 Largest Induced Pluripotent Stem Cells (iPSc) Players Market Share by Revenue 21
3.6.3 Mergers & Acquisitions, Expansion 21
4 Induced Pluripotent Stem Cells (iPSc) Industry Chain Analysis 22
4.1 Induced Pluripotent Stem Cells (iPSc) Industry Chain Analysis 22
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials 22
4.3 Midstream Market Analysis 23
4.4 Downstream Customer Analysis 23
5 The Development and Dynamics of Induced Pluripotent Stem Cells (iPSc) Market 25
5.1 Key Development Trends 25
5.2 Driving Factors 25
5.3 Market Challenges 25
5.4 Market Restraints 26
5.5 Industry News 26
5.5.1 New Product Developments 26
5.5.2 Mergers & Acquisitions 26
5.5.3 Expansions 26
5.5.4 Collaboration/Supply Contracts 26
5.6 Industry Policies 26
6 Induced Pluripotent Stem Cells (iPSc) Market Segmentation by Type 27
6.1 Evaluation Matrix of Segment Market Development Potential (Type) 27
6.2 Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Type (2017-2022) 28
6.3 Global Induced Pluripotent Stem Cells (iPSc) Market Size Market Share by Type (2017-2022) 29
6.4 Global Induced Pluripotent Stem Cells (iPSc) Price by Type (2017-2022) 30
7 Induced Pluripotent Stem Cells (iPSc) Market Segmentation by Application 31
7.1 Evaluation Matrix of Segment Market Development Potential (Application) 31
7.2 Global Induced Pluripotent Stem Cells (iPSc) Market Sales by Application (2017-2022) 32
7.3 Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) by Application (2017-2022) 33
7.4 Global Induced Pluripotent Stem Cells (iPSc) Sales Growth Rate by Application (2017-2022) 34
8 Induced Pluripotent Stem Cells (iPSc) Market Segmentation by Region 35
8.1 Global Induced Pluripotent Stem Cells (iPSc) Sales by Region 35
8.1.1 Global Induced Pluripotent Stem Cells (iPSc) Sales by Region 35
8.1.2 Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region 35
8.2 North America 36
8.2.1 North America Induced Pluripotent Stem Cells (iPSc) Sales by Country 36
8.2.2 U.S. 37
8.2.3 Canada 37
8.2.4 Mexico 37
8.3 Europe 37
8.3.1 Europe Induced Pluripotent Stem Cells (iPSc) Sales by Country 38
8.3.2 Germany 38
8.3.3 France 38
8.3.4 U.K. 38
8.3.5 Italy 39
8.3.6 Russia 39
8.4 Asia Pacific 39
8.4.1 Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales by Region 39
8.4.2 China 40
8.4.3 Japan 40
8.4.4 South Korea 40
8.4.5 India 40
8.4.6 Southeast Asia 40
8.5 South America 40
8.5.1 South America Induced Pluripotent Stem Cells (iPSc) Sales by Country 41
8.5.2 Brazil 41
8.5.3 Argentina 41
8.5.4 Columbia 41
8.6 Middle East and Africa 41
8.6.1 Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Sales by Region 42
8.6.2 Saudi Arabia 42
8.6.3 UAE 42
8.6.4 Egypt 42
8.6.5 Nigeria 43
8.6.6 South Africa 43
9 Key Companies Profiled 44
9.1 Lonza 44
9.1.1 Lonza Induced Pluripotent Stem Cells (iPSc) Basic Information 44
9.1.2 Lonza Induced Pluripotent Stem Cells (iPSc) Product Overview 44
9.1.3 Lonza Induced Pluripotent Stem Cells (iPSc) Product Market Performance 44
9.1.4 Lonza Business Overview 45
9.1.5 Lonza Induced Pluripotent Stem Cells (iPSc) SWOT Analysis 45
9.1.6 Lonza Recent Developments 45
9.2 Axol Bioscience Ltd. 46
9.2.1 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Basic Information 46
9.2.2 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview 46
9.2.3 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Product Market Performance 46
9.2.4 Axol Bioscience Ltd. Business Overview 47
9.2.5 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) SWOT Analysis 47
9.2.6 Axol Bioscience Ltd. Recent Developments 47
9.3 Evotec 47
9.3.1 Evotec Induced Pluripotent Stem Cells (iPSc) Basic Information 47
9.3.2 Evotec Induced Pluripotent Stem Cells (iPSc) Product Overview 48
9.3.3 Evotec Induced Pluripotent Stem Cells (iPSc) Product Market Performance 48
9.3.4 Evotec Business Overview 48
9.3.5 Evotec Induced Pluripotent Stem Cells (iPSc) SWOT Analysis 49
9.3.6 Evotec Recent Developments 49
9.4 Hitachi Ltd. 49
9.4.1 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Basic Information 49
9.4.2 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview 50
9.4.3 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Product Market Performance 50
9.4.4 Hitachi Ltd. Business Overview 50
9.4.5 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) SWOT Analysis 50
9.4.6 Hitachi Ltd. Recent Developments 51
9.5 Merck KGaA 51
9.5.1 Merck KGaA Induced Pluripotent Stem Cells (iPSc) Basic Information 51
9.5.2 Merck KGaA Induced Pluripotent Stem Cells (iPSc) Product Overview 51
9.5.3 Merck KGaA Induced Pluripotent Stem Cells (iPSc) Product Market Performance 52
9.5.4 Merck KGaA Business Overview 52
9.5.5 Merck KGaA Induced Pluripotent Stem Cells (iPSc) SWOT Analysis 52
9.5.6 Merck KGaA Recent Developments 52
9.6 REPROCELL Inc. 53
9.6.1 REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information 53
9.6.2 REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview 53
9.6.3 REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Product Market Performance 53
9.6.4 REPROCELL Inc. Business Overview 54
9.6.5 REPROCELL Inc. Recent Developments 54
9.7 Fate Therapeutics 54
9.7.1 Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Basic Information 54
9.7.2 Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Product Overview 55
9.7.3 Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Product Market Performance 55
9.7.4 Fate Therapeutics Business Overview 55
9.7.5 Fate Therapeutics Recent Developments 55
9.8 Thermo Fisher Scientific, Inc. 56
9.8.1 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information 56
9.8.2 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview 56
9.8.3 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Product Market Performance 56
9.8.4 Thermo Fisher Scientific, Inc. Business Overview 57
9.8.5 Thermo Fisher Scientific, Inc. Recent Developments 57
9.9 StemCellFactory III 57
9.9.1 StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Basic Information 57
9.9.2 StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Product Overview 58
9.9.3 StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Product Market Performance 58
9.9.4 StemCellFactory III Business Overview 58
9.9.5 StemCellFactory III Recent Developments 58
9.10 Applied StemCell Inc. 59
9.10.1 Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information 59
9.10.2 Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview 59
9.10.3 Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Product Market Performance 59
9.10.4 Applied StemCell Inc. Business Overview 60
9.10.5 Applied StemCell Inc. Recent Developments 60
9.11 Fujifilm Holding Corporation (CDI) 60
9.11.1 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Basic Information 60
9.11.2 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Product Overview 61
9.11.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Product Market Performance 61
9.11.4 Fujifilm Holding Corporation (CDI) Business Overview 61
9.11.5 Fujifilm Holding Corporation (CDI) Recent Developments 61
9.12 Ncardia 62
9.12.1 Ncardia Induced Pluripotent Stem Cells (iPSc) Basic Information 62
9.12.2 Ncardia Induced Pluripotent Stem Cells (iPSc) Product Overview 62
9.12.3 Ncardia Induced Pluripotent Stem Cells (iPSc) Product Market Performance 62
9.12.4 Ncardia Business Overview 63
9.12.5 Ncardia Recent Developments 63
9.13 Sumitomo Dainippon harma 63
9.13.1 Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Basic Information 63
9.13.2 Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Product Overview 64
9.13.3 Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Product Market Performance 64
9.13.4 Sumitomo Dainippon harma Business Overview 64
9.13.5 Sumitomo Dainippon harma Recent Developments 64
9.14 Astellas Pharma Inc 65
9.14.1 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Basic Information 65
9.14.2 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Product Overview 65
9.14.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Product Market Performance 65
9.14.4 Astellas Pharma Inc Business Overview 66
9.14.5 Astellas Pharma Inc Recent Developments 66
9.15 Pluricell Biotech 66
9.15.1 Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Basic Information 66
9.15.2 Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Product Overview 67
9.15.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Product Market Performance 67
9.15.4 Pluricell Biotech Business Overview 67
9.15.5 Pluricell Biotech Recent Developments 67
9.16 Cell Inspire Biotechnology 68
9.16.1 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Basic Information 68
9.16.2 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Product Overview 68
9.16.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Product Market Performance 68
9.16.4 Cell Inspire Biotechnology Business Overview 69
9.16.5 Cell Inspire Biotechnology Recent Developments 69
10 Induced Pluripotent Stem Cells (iPSc) Market Forecast by Region 106
10.1 Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast 106
10.2 Global Induced Pluripotent Stem Cells (iPSc) Market Forecast by Region 106
10.2.1 North America Market Size Forecast by Country 107
10.2.2 Europe Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country 108
10.2.3 Asia Pacific Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Region 108
10.2.4 South America Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country 109
10.2.5 Middle East and Africa Forecasted Consumption of Induced Pluripotent Stem Cells (iPSc) by Country 109
11 Forecast Market by Type and by Application (2022-2028) 111
11.1 Global Induced Pluripotent Stem Cells (iPSc) Market Forecast by Type (2022-2028) 111
11.1.1 Global Forecasted Sales of Induced Pluripotent Stem Cells (iPSc) by Type (2022-2028) 111
11.1.2 Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Type (2022-2028) 111
11.1.3 Global Forecasted Price of Induced Pluripotent Stem Cells (iPSc) by Type (2022-2028) 112
11.2 Global Induced Pluripotent Stem Cells (iPSc) Market Forecast by Application (2022-2028) 112
11.2.1 Global Induced Pluripotent Stem Cells (iPSc) Sales (K Units) Forecast by Application 112
11.2.2 Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) Forecast by Application (2022-2028) 113
12 Conclusion and Key Findings 114
List of Figures
?List of Tables
Table 1. Global Induced Pluripotent Stem Cells (iPSc) Sales (K Units) by Manufacturers (2017-2022) 1
Table 2. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Manufacturers (2017-2022) 2
Table 3. Global Induced Pluripotent Stem Cells (iPSc) Revenue (M USD) by Manufacturers (2017-2022) 3
Table 4. Global Induced Pluripotent Stem Cells (iPSc) Revenue Share by Manufacturers (2017-2022) 3
Table 5. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Induced Pluripotent Stem Cells (iPSc) as of 2020) 4
Table 6. Global Market Induced Pluripotent Stem Cells (iPSc) Average Price (USD/Unit) of Key Manufacturers (2017-2022) 5
Table 7. Manufacturers Induced Pluripotent Stem Cells (iPSc) Sales Sites and Area Served 6
Table 8. Manufacturers Induced Pluripotent Stem Cells (iPSc) Product Type 6
Table 9. Global Induced Pluripotent Stem Cells (iPSc) Manufacturers Market Concentration Ratio (CR5 and HHI) 8
Table 10. Mergers & Acquisitions, Expansion Plans 9
Table 11. Industry Chain Map of Induced Pluripotent Stem Cells (iPSc) 10
Table 12. Raw Materials 10
Table 13. Midstream Market Analysis 11
Table 14. Downstream Customer Analysis 11
Table 15. Key Development Trends 13
Table 16. Driving Factors 13
Table 17. Induced Pluripotent Stem Cells (iPSc) Market Challenges 13
Table 18. Market Restraints 14
Table 19. Global Induced Pluripotent Stem Cells (iPSc) Sales by Type (K Units) 15
Table 20. Global Induced Pluripotent Stem Cells (iPSc) Market Size by Type (M USD) 16
Table 21. Global Induced Pluripotent Stem Cells (iPSc) Sales (K Units) by Type (2017-2022) 16
Table 22. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Type (2017-2022) 16
Table 23. Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) by Type (2017-2022) 17
Table 24. Global Induced Pluripotent Stem Cells (iPSc) Market Size Share by Type (2017-2022) 17
Table 25. Global Induced Pluripotent Stem Cells (iPSc) Price (USD/Unit) by Type (2017-2022) 18
Table 26. Global Induced Pluripotent Stem Cells (iPSc) Sales (K Units) by Application 19
Table 27. Global Induced Pluripotent Stem Cells (iPSc) Market Size by Application 20
Table 28. Global Induced Pluripotent Stem Cells (iPSc) Sales by Application (2017-2022) & (K Units) 20
Table 29. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Application (2017-2022) 20
Table 30. Global Induced Pluripotent Stem Cells (iPSc) Sales by Application (2017-2022) & (M USD) 21
Table 31. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Application (2017-2022) 21
Table 32. Global Induced Pluripotent Stem Cells (iPSc) Sales Growth Rate by Application (2017-2022) 22
Table 33. Global Induced Pluripotent Stem Cells (iPSc) Sales by Region (2017-2022) & (K Units) 23
Table 34. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region (2017-2022) 23
Table 35. North America Induced Pluripotent Stem Cells (iPSc) Sales by Country (2017-2022) & (K Units) 24
Table 36. Europe Induced Pluripotent Stem Cells (iPSc) Sales by Country (2017-2022) & (K Units) 26
Table 37. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales by Region (2017-2022) & (K Units) 27
Table 38. South America Induced Pluripotent Stem Cells (iPSc) Sales by Country (2017-2022) & (K Units) 29
Table 39. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Sales by Region (2017-2022) & (K Units) 30
Table 40. Lonza Induced Pluripotent Stem Cells (iPSc) Basic Information 32
Table 41. Lonza Induced Pluripotent Stem Cells (iPSc) Product Overview 32
Table 42. Lonza Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 32
Table 43. Lonza Business Overview 33
Table 44. Lonza Induced Pluripotent Stem Cells (iPSc) SWOT Analysis 33
Table 45. Lonza Recent Developments 33
Table 46. Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Basic Information 34
Table 47. Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview 34
Table 48. Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 34
Table 49. Axol Bioscience Ltd. Business Overview 35
Table 50. Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) SWOT Analysis 35
Table 51. Axol Bioscience Ltd. Recent Developments 35
Table 52. Evotec Induced Pluripotent Stem Cells (iPSc) Basic Information 35
Table 53. Evotec Induced Pluripotent Stem Cells (iPSc) Product Overview 36
Table 54. Evotec Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 36
Table 55. Evotec Business Overview 36
Table 56. Evotec Induced Pluripotent Stem Cells (iPSc) SWOT Analysis 37
Table 57. Evotec Recent Developments 37
Table 58. Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Basic Information 37
Table 59. Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview 38
Table 60. Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 38
Table 61. Hitachi Ltd. Business Overview 38
Table 62. Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) SWOT Analysis 38
Table 63. Hitachi Ltd. Recent Developments 39
Table 64. Merck KGaA Induced Pluripotent Stem Cells (iPSc) Basic Information 39
Table 65. Merck KGaA Induced Pluripotent Stem Cells (iPSc) Product Overview 39
Table 66. Merck KGaA Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 40
Table 67. Merck KGaA Business Overview 40
Table 68. Merck KGaA Induced Pluripotent Stem Cells (iPSc) SWOT Analysis 40
Table 69. Merck KGaA Recent Developments 40
Table 70. REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information 41
Table 71. REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview 41
Table 72. REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 41
Table 73. REPROCELL Inc. Business Overview 42
Table 74. REPROCELL Inc. Recent Developments 42
Table 75. Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Basic Information 42
Table 76. Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Product Overview 43
Table 77. Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 43
Table 78. Fate Therapeutics Business Overview 43
Table 79. Fate Therapeutics Recent Developments 43
Table 80. Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information 44
Table 81. Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview 44
Table 82. Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 44
Table 83. Thermo Fisher Scientific, Inc. Business Overview 45
Table 84. Thermo Fisher Scientific, Inc. Recent Developments 45
Table 85. StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Basic Information 45
Table 86. StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Product Overview 46
Table 87. StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 46
Table 88. StemCellFactory III Business Overview 46
Table 89. StemCellFactory III Recent Developments 46
Table 90. Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information 47
Table 91. Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview 47
Table 92. Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 47
Table 93. Applied StemCell Inc. Business Overview 48
Table 94. Applied StemCell Inc. Recent Developments 48
Table 95. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Basic Information 48
Table 96. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Product Overview 49
Table 97. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 49
Table 98. Fujifilm Holding Corporation (CDI) Business Overview 49
Table 99. Fujifilm Holding Corporation (CDI) Recent Developments 49
Table 100. Ncardia Induced Pluripotent Stem Cells (iPSc) Basic Information 50
Table 101. Ncardia Induced Pluripotent Stem Cells (iPSc) Product Overview 50
Table 102. Ncardia Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 50
Table 103. Ncardia Business Overview 51
Table 104. Ncardia Recent Developments 51
Table 105. Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Basic Information 51
Table 106. Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Product Overview 52
Table 107. Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 52
Table 108. Sumitomo Dainippon harma Business Overview 52
Table 109. Sumitomo Dainippon harma Recent Developments 52
Table 110. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Basic Information 53
Table 111. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Product Overview 53
Table 112. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 53
Table 113. Astellas Pharma Inc Business Overview 54
Table 114. Astellas Pharma Inc Recent Developments 54
Table 115. Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Basic Information 54
Table 116. Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Product Overview 55
Table 117. Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 55
Table 118. Pluricell Biotech Business Overview 55
Table 119. Pluricell Biotech Recent Developments 55
Table 120. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Basic Information 56
Table 121. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Product Overview 56
Table 122. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 56
Table 123. Cell Inspire Biotechnology Business Overview 57
Table 124. Cell Inspire Biotechnology Recent Developments 57
Table 125. Global Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Region (K Units) 94
Table 126. Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Region (M USD) 95
Table 127. North America Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Country (2022-2028) & (K Units) 95
Table 128. North America Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country (2022-2028) & (M USD) 95
Table 129. Europe Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Country (2022-2028) & (K Units) 96
Table 130. Europe Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country (2022-2028) & (M USD) 96
Table 131. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Region (2022-2028) & (K Units) 96
Table 132. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Region (2022-2028) & (M USD) 97
Table 133. South America Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Country (2022-2028) & (K Units) 97
Table 134. South America Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country (2022-2028) & (M USD) 97
Table 135. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Consumption Forecast by Country (2022-2028) & (Units) 97
Table 136. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country (2022-2028) & (M USD) 98
Table 137. Global Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Type (2022-2028) & (K Units) 99
Table 138. Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Type (2022-2028) & (M USD) 99
Table 139. Global Induced Pluripotent Stem Cells (iPSc) Price Forecast by Type (2022-2028) & (USD/Unit) 100
Table 140. Global Induced Pluripotent Stem Cells (iPSc) Sales (K Units) Forecast by Application (2022-2028) 100
Table 141. Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Application (2022-2028) & (M USD) 101
List of Figures
Figure 1. Induced Pluripotent Stem Cells (iPSc) Sales Share by Manufacturers in 2020 2
Figure 2. Global Induced Pluripotent Stem Cells (iPSc) Revenue Share by Manufacturers in 2020 4
Figure 3. Induced Pluripotent Stem Cells (iPSc) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 5
Figure 4. Global Market Induced Pluripotent Stem Cells (iPSc) Average Price (USD/Unit) of Key Manufacturers in 2020 6
Figure 5. The Global 5 and 10 Largest Players: Market Share by Induced Pluripotent Stem Cells (iPSc) Revenue in 2020 9
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type) 15
Figure 7. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Type 16
Figure 8. Sales Market Share of Induced Pluripotent Stem Cells (iPSc) by Type (2017-2022) 17
Figure 9. Sales Market Share of Induced Pluripotent Stem Cells (iPSc) by Type in 2020 17
Figure 10. Market Size Share of Induced Pluripotent Stem Cells (iPSc) by Type (2017-2022) 17
Figure 11. Market Size Market Share of Induced Pluripotent Stem Cells (iPSc) by Type in 2020 18
Figure 12. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Application 20
Figure 13. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Application (2017-2022) 21
Figure 14. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Application in 2020 21
Figure 15. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Application (2017-2022) 22
Figure 16. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Application in 2020 22
Figure 17. Global Induced Pluripotent Stem Cells (iPSc) Sales Growth Rate by Application (2017-2022) 22
Figure 18. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region (2017-2022) 23
Figure 19. North America Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units) 24
Figure 20. North America Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Country in 2020 24
Figure 21. U.S. Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units) 25
Figure 22. Canada Induced Pluripotent Stem Cells (iPSc) Sales (K Units) and Growth Rate (2017-2022) 25
Figure 23. Mexico Induced Pluripotent Stem Cells (iPSc) Sales (Units) and Growth Rate (2017-2022) 25
Figure 24. Europe Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units) 25
Figure 25. Europe Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Country in 2020 26
Figure 26. Germany Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units) 26
Figure 27. France Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units) 26
Figure 28. U.K. Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units) 26
Figure 29. Italy Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units) 27
Figure 30. Russia Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units) 27
Figure 31. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (K Units) 27
Figure 32. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region in 2020 27
Figure 33. China Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units) 28
Figure 34. Japan Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units) 28
Figure 35. South Korea Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units) 28
Figure 36. India Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units) 28
Figure 37. Southeast Asia Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units) 28
Figure 38. South America Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (K Units) 28
Figure 39. South America Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Country in 2020 29
Figure 40. Brazil Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units) 29
Figure 41. Argentina Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units) 29
Figure 42. Columbia Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units) 29
Figure 43. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (K Units) 29
Figure 44. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region in 2020 30
Figure 45. Saudi Arabia Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units) 30
Figure 46. UAE Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units) 30
Figure 47. Egypt Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units) 30
Figure 48. Nigeria Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units) 31
Figure 49. South Africa Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units) 31
Figure 50. Global Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Volume (2017-2028) & (K Units) 94
Figure 51. Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Value (2017-2028) & (M USD) 94
Figure 52. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share Forecast by Type (2022-2028) 99
US $
Euro €
GBP £